27-hydroxycholesterol has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Holly, JMP; Mashat, RM; Perks, CM; Zielinska, HA | 1 |
| Baek, AE; Boppart, MD; Boppart, SA; Das Gupta, A; Deng, YH; Dvoretskiy, SV; Henn, MA; Kong, H; Krawczynska, N; Ma, L; Madak-Erdogan, Z; McDowell, HB; Nelson, AT; Nelson, ER; Park, J; Smith, BP; Sorrells, JE; Sprenger, A; You, S | 1 |
| Biasi, F; Gamba, P; Leoni, V; Lizard, G; Poli, G; Sassi, K | 1 |
| Abreu, L; Antenora, A; Arnoldi, A; Baets, J; Bassi, MT; Bauer, P; Bis, DM; Björkhem, I; Criscuolo, C; De Jonghe, P; Deconinck, T; Filla, A; Fischer, I; Fraidakis, MJ; Hauser, S; Höflinger, P; Jägle, C; Jardim, LB; Klopstock, T; Lourenco, CM; Marques, W; Martinuzzi, A; Martus, P; Meisner, C; Paucar, M; Rattay, TW; Saute, JA; Scarlato, M; Schöls, L; Schüle, R; Smets, K; Stendel, C; Wiethoff, S; Züchner, S | 1 |
| Biasi, F; Caccia, C; Degiuli, M; Devitt, A; Dias, IHK; Griffiths, HR; Iaia, N; Leoni, V; Milic, I; Nano, M; Pitt, AR; Poli, G; Rossin, D; Scoppapietra, L; Solej, M; Spickett, CM; Volante, M | 1 |
| Baek, AE; Burdette, JE; Chen, JJ; He, S; Ma, L; Nelson, AT; Nelson, ER; Vardanyan, A; Vembar, V | 1 |
| Biasi, F; Gamba, P; Gargiulo, S; Giaccone, G; Guglielmotto, M; Iuliano, L; Leonarduzzi, G; Mauro, A; Monteleone, D; Poli, G; Tamagno, E; Testa, G; Zerbinati, C | 1 |
| Björkhem, I; Del Puppo, M; Dotti, MT; Federico, A; Gallus, GN; Magni, A; Mignarri, A | 1 |
| Ghribi, O; Marwarha, G; Rhen, T; Schommer, T | 1 |
1 review(s) available for 27-hydroxycholesterol and Disease Exacerbation
| Article | Year |
|---|---|
Role of 27-hydroxycholesterol and its metabolism in cancer progression: Human studies.
Topics: Animals; Biomarkers, Tumor; Cholestanetriol 26-Monooxygenase; Cytochrome P450 Family 7; Disease Progression; Humans; Hydroxycholesterols; Neoplasms; Steroid Hydroxylases | 2022 |
1 trial(s) available for 27-hydroxycholesterol and Disease Exacerbation
| Article | Year |
|---|---|
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Topics: Adolescent; Adult; Atorvastatin; Biomarkers; Case-Control Studies; Cell Proliferation; Cross-Sectional Studies; Cytochrome P450 Family 7; Disease Progression; Double-Blind Method; Family; Female; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induced Pluripotent Stem Cells; Male; Middle Aged; Mutation; Neurites; Oxysterols; Pedigree; Severity of Illness Index; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; Young Adult | 2017 |
7 other study(ies) available for 27-hydroxycholesterol and Disease Exacerbation
| Article | Year |
|---|---|
A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol, LDL; Disease Progression; Epithelial-Mesenchymal Transition; ErbB Receptors; Estrogen Receptor beta; Female; Humans; Hydroxycholesterols; Insulin-Like Growth Factor I; Metabolome; Neoplasm Invasiveness; Receptor, IGF Type 1; Signal Transduction; Triple Negative Breast Neoplasms | 2021 |
The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression.
Topics: Animals; Cell Line, Tumor; Disease Progression; Estrogen Receptor Modulators; Extracellular Vesicles; Female; Hydroxycholesterols; Hypercholesterolemia; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neutrophils; RAW 264.7 Cells | 2021 |
Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration.
Topics: Caco-2 Cells; Cell Survival; Colorectal Neoplasms; Disease Progression; Humans; Hydroxycholesterols; Neoplasm Invasiveness; Signal Transduction | 2019 |
Host CYP27A1 expression is essential for ovarian cancer progression.
Topics: Animals; B7-H1 Antigen; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cholestanetriol 26-Monooxygenase; Cholesterol, Dietary; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hydroxycholesterols; Mice; Myeloid-Derived Suppressor Cells; Ovarian Neoplasms; Prognosis; Progression-Free Survival; Xenograft Model Antitumor Assays | 2019 |
Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine.
Topics: Acetylcysteine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Disease Progression; Humans; Hydroxycholesterols; Neurons; Oxidative Stress; Up-Regulation | 2014 |
Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Topics: Adolescent; Adult; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Cholestanol; Cholestenones; Cholesterol; Disease Progression; Female; Humans; Hydroxycholesterols; Lipid Metabolism; Male; Middle Aged; Prognosis; Xanthomatosis, Cerebrotendinous; Young Adult | 2016 |
The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.
Topics: alpha-Synuclein; Cell Line, Tumor; Disease Progression; Down-Regulation; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Hydroxycholesterols; Liver X Receptors; Neuroblastoma; Orphan Nuclear Receptors; Parkinson Disease; Signal Transduction; Tyrosine 3-Monooxygenase; Up-Regulation | 2011 |